Press releases
- Press releases
- Browse
Press releases
New summary from Partneringdesk highlights trends in dealmaking from the top pharma and biotech companies More
Zambon will license Vectura's PowderHale(tm) pulmonary formulation technology for the development and commercialisation of a new dry powder inhaler product. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Jan 2011 - 11 pages - $500
Mar 2010 - 414 pages - $690
Nov 2009 - 17 pages - $1,000
Feb 2009 - 242 pages - $690
Apr 2010 - 5 pages - $500
Oct 2010 - 59 pages - $1,000
Jan 2011 - 38 pages - $515
Apr 2010 - 42 pages - $515
Mar 2010 - 30 pages - $515
May 2009 - 32 pages - $515
Your selection
Browse By
- Industry sector
- Analysis
- Clean room
- Computing
- Delivery systems
- Disposables
- Electrical equipment
- Electronic components
- Environmental control
- Extrusion
- Filtration
- Fitness/Exercise
- Labelling
- Materials
- Motors/Motion control devices
- Moulding
- Other
- Packaging
- Pumps/Valves
- Sterilization
- Surface treatment
- Surgical products
- Testing equipment/Services
- Tubing
- Therapeutic target
- Adult respiratory distress syndrome
- Allergy, respiratory
- Asthma
- Asthma, bronchospasm
- Bronchitis
- Chest disorder (other)
- Chlamydia pneumoniae
- Chronic obstructive pulmonary disease
- Cough
- Cystic fibrosis
- Dysplasia, bronchopulmonary
- Emphysema
- Granulomatous lung disease sarcoidosis
- Idiopathic respiratory distress syndrome
- Meconium aspiration syndrome
- Nasal disorder (other)
- Obstructive airway disease
- Pneumonia
- Pneumonocystis carinii lung infection
- Pseudomonas lung infection
- Respiratory disorder (other)
- Respiratory syncytial virus
- Respiratory tract infections
- Rhinitis
- Rhinovirus (common cold)
- Sinusitis
- Sleep apnea
- Throat disorder (other)
- Tuberculosis
- Year
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us